Pancreatic Cancer
Pancreatic cancer is a serious condition that occurs when malignant cells form in the tissues of the pancreas, often leading to symptoms like abdominal pain, weight loss, and jaundice.
Pancreatic Cancer: CEB-01 Treatment Study
We are exploring a new treatment called CEB-01 for people with pancreatic cancer to see how safe it is and if it may help improve their condition.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you at least 18 years old?
- Are you currently pregnant or breastfeeding?
- Have you had major surgery in the past 14 days?
- Have you fully recovered from any chemotherapy, immunotherapy, or radiotherapy effects?
- Do you have any major health issues that would affect your ability to undergo treatment?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Hospital Clinic De Barcelona
General Surgery
El Altet, Spain
University Hospital Virgen Del Rocio S.L.
General Surgery
Huelva, Spain
Hospital Clinico San Carlos
General Surgery
Madrid, Spain
Sponsor: Cebiotex S.L.
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.